秦国庆,罗志刚,王毅,李建军,钱坤.舒莱预防肾移植术后急性排斥反应的临床研究.[J].中南医学科学杂志.,2008,(3):.
舒莱预防肾移植术后急性排斥反应的临床研究
Two Doses Regimen of Simulect in the Clinical Research of Acute Renal Allograft Rejection
  
DOI:
中文关键词:  舒莱  急性排斥反应  肾移植
英文关键词:Simulect  acute rejection  renal transplantation  
基金项目:
秦国庆  罗志刚  王毅  李建军  钱坤
南华大学第二附属医院泌外肾移植科,湖南衡阳421001
摘要点击次数: 695
全文下载次数: 0
中文摘要:
      目的 探讨舒莱诱导治疗预防同种异体肾移植术后急性排斥反应的临床效果.方法 回顾分析65例同种异体肾移植患者临床资料,其中38例没有应用舒莱(对照组);27例应用两剂舒莱进行诱导治疗(治疗组),两组患者肾移植术后均以普乐可复、吗替麦考酚酯和皮质激素预防排斥反应.比较两组肾移植患者术后6个月内急性排斥反应的发生率、术后血肌酐下降速度、副反应发生情况和1年人/肾存活率.结果 对照组术后急性排斥反应率为26.32%(10/38),舒莱组术后急性排斥反应率为7.41%(2/27),两组比较差异有显著性(P<0.05);与对照组比较,舒莱组移植肾的血肌酐下降速度快(P(0.05),但1年人/肾存活率无明显差异(P>0.05).结论 肾移植受者在应用常规免疫抑制剂的基础上结合舒莱免疫诱导治疗,能有效降低术后急性排斥反应发生率,且患者有较好的耐受性.
英文摘要:
      Objective To investigate its clinical effect of Simulect in prevention of acute rejection in renal transplant recipients. Methods A randomized control clinical trial was designed with 65 renal transplant recipients from 01/2004 to 05/2006 in our hospital.38 cases were not treated with Simulect(control group),27 cases were treated with Simulect induction therapy(therapy group).Both groups received baseline triple immunosuppression with the Prograf,MMF and Steroids.6-month incidences of acute rejection,blood ...
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=D1E0470051E8229196FF5618D85A7A95C7C958F9F5B22142E953E1BFE6217A50FEDF5A730B482FBFEE1069C18451B9920823709E97EF4C629225023833C905115EB9CD2E8AAFFFFC533BCB320A7947C660692E4FF6F11A185E4F85A7894B604A&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=67289AFF6305E306&aid=40636430&vid=&iid=38B194292C032A66&sid=&eid=&fileno=200803127&flag=1&is_more=0">